HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$43.71
Day range
$41.23 - $45.00
Year range
$5.65 - $65.60
Market cap
2.15B USD
Avg Volume
476.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 8.90M | 741.72% |
Operating expense | 7.82M | 13.66% |
Net income | -5.96M | 65.96% |
Net profit margin | -66.98 | 95.96% |
Earnings per share | -0.11 | 73.81% |
EBITDA | -13.32M | 34.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 646.29M | 113.09% |
Total assets | 691.41M | 102.46% |
Total liabilities | 33.74M | -19.74% |
Total equity | 657.68M | — |
Shares outstanding | 52.16M | — |
Price to book | 3.47 | — |
Return on assets | -5.01% | — |
Return on capital | -5.08% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.96M | 65.96% |
Cash from operations | -10.02M | 33.43% |
Cash from investing | -190.88M | -1,167.95% |
Cash from financing | 2.76M | 423.67% |
Net change in cash | -198.14M | -6,018.19% |
Free cash flow | -10.33M | -41.06% |
About
Founded
2017
Website
Employees
69